Novavax NVAX
NASDAQ NVAX
$10.46 -0.14 (-1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Novavax (NVAX) Depreciation and Depletion (2021)

Updated

Novavax (NVAX) recorded Depreciation and Depletion of $951,000 in Q1 2021.

Analysis

Novavax (NVAX) Depreciation and Depletion (2021) Analysis & Trends

For FY2013, Novavax reported Depreciation and Depletion of $200,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Novavax 1.72 Bn -1.28 Bn 42.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 951,000.00
API Access

Novavax Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=NVAX&period=max&api_key=YOUR_API_KEY